Skip to content

Home
Team
Portfolio
News
- TCG News
- Portfolio News
Careers
Contact

Menu

Home
Team
Portfolio
News
- TCG News
- Portfolio News
Careers
Contact

February 2019

Immune Design acquired by Merck for approx. $300M

Portfolio News / By admin

February 21, 2019

Kallyope Inc. Appoints Brett Lauring as Chief Medical Officer

Portfolio News / By admin

February 5, 2019

Search for:

Recent Posts

Revolution Medicines Announces Commencement of Public Offering of Common Stock
NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2022 Financial Results
Revolution Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Update on Corporate Progress
eFFECTOR Therapeutics Announces Positive Top-Line Results from Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID
Neurona Therapeutics Announces FDA Clearance of Expanded Inclusion Criteria for Phase I/II Clinical Trial of NRTX-1001 Regenerative Cell Therapy in Patients with Dominant Hemisphere Drug-Resistant Focal Epilepsy

Recent Comments

Archives

Categories

Portfolio News
TCG News

The Column Group

Copyright © 2022. The Column Group | Privacy Policy | Terms of Use
Website developed by CP Communications

Scroll to Top